These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 26652899)

  • 1. Measures of outcome for stimulant trials: ACTTION recommendations and research agenda.
    Kiluk BD; Carroll KM; Duhig A; Falk DE; Kampman K; Lai S; Litten RZ; McCann DJ; Montoya ID; Preston KL; Skolnick P; Weisner C; Woody G; Chandler R; Detke MJ; Dunn K; Dworkin RH; Fertig J; Gewandter J; Moeller FG; Ramey T; Ryan M; Silverman K; Strain EC
    Drug Alcohol Depend; 2016 Jan; 158():1-7. PubMed ID: 26652899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: Findings from 13 multisite randomized clinical trials.
    Amin-Esmaeili M; Farokhnia M; Susukida R; Leggio L; Johnson RM; Crum RM; Mojtabai R
    Addiction; 2024 May; 119(5):833-843. PubMed ID: 38197836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Patient-Centered Outcomes in Clinical Trials of Procedural Sedation, Part 1 Efficacy: Sedation Consortium on Endpoints and Procedures for Treatment, Education, and Research Recommendations.
    Williams MR; Ward DS; Carlson D; Cravero J; Dexter F; Lightdale JR; Mason KP; Miner J; Vargo JJ; Berkenbosch JW; Clark RM; Constant I; Dionne R; Dworkin RH; Gozal D; Grayzel D; Irwin MG; Lerman J; O'Connor RE; Pandharipande P; Rappaport BA; Riker RR; Tobin JR; Turk DC; Twersky RS; Sessler DI
    Anesth Analg; 2017 Mar; 124(3):821-830. PubMed ID: 27622720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research.
    Stoops WW; Rush CR
    Expert Rev Clin Pharmacol; 2014 May; 7(3):363-74. PubMed ID: 24716825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients.
    Angelo FN; McDonell MG; Lewin MR; Srebnik D; Lowe J; Roll J; Ries R
    Drug Alcohol Depend; 2013 Jul; 131(1-2):162-5. PubMed ID: 23273776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validating the clinical relevance of alternative stimulant use treatment outcome measures by examining their association with 3-month follow-up outcomes.
    Miguel AQC; Smith CL; Burduli E; Roll JM; McPherson SM
    Exp Clin Psychopharmacol; 2021 Jun; 29(3):288-293. PubMed ID: 34264739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
    Camacho A; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors and Outcomes of Twelve-Step Sponsorship of Stimulant Users: Secondary Analyses of a Multisite Randomized Clinical Trial.
    Wendt DC; Hallgren KA; Daley DC; Donovan DM
    J Stud Alcohol Drugs; 2017 Mar; 78(2):287-295. PubMed ID: 28317510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?
    Kiluk BD; Fitzmaurice GM; Strain EC; Weiss RD
    Addiction; 2019 Jan; 114(1):9-15. PubMed ID: 29900624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Men and women from the STRIDE clinical trial: An assessment of stimulant abstinence symptom severity at residential treatment entry.
    Chartier KG; Sanchez K; Killeen TK; Burrow A; Carmody T; Greer TL; Trivedi MH
    Am J Addict; 2015 Jun; 24(4):336-40. PubMed ID: 25694201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stimulant dependence].
    Kishimoto H
    Ryoikibetsu Shokogun Shirizu; 2003; (40):505-6. PubMed ID: 14626171
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of contingency management and cognitive-behavioral approaches for stimulant-dependent individuals.
    Rawson RA; McCann MJ; Flammino F; Shoptaw S; Miotto K; Reiber C; Ling W
    Addiction; 2006 Feb; 101(2):267-74. PubMed ID: 16445555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies.
    Herin DV; Rush CR; Grabowski J
    Ann N Y Acad Sci; 2010 Feb; 1187():76-100. PubMed ID: 20201847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuse.
    Warden D; Trivedi MH; Greer TL; Nunes E; Grannemann BD; Horigian VE; Somoza E; Ring K; Kyle T; Szapocznik J
    Contemp Clin Trials; 2012 Jan; 33(1):29-37. PubMed ID: 21946515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.
    ; ; ;
    J Addict Med; 2024 May-Jun 01; 18(1S Suppl 1):1-56. PubMed ID: 38669101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome measures for clinical trials in fragile X syndrome.
    Berry-Kravis E; Hessl D; Abbeduto L; Reiss AL; Beckel-Mitchener A; Urv TK;
    J Dev Behav Pediatr; 2013 Sep; 34(7):508-22. PubMed ID: 24042082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Suicidal Ideation and Behavior: Report of the International Society for CNS Clinical Trials and Methodology Consensus Meeting.
    Chappell PB; Stewart M; Alphs L; DiCesare F; DuBrava S; Harkavy-Friedman J; Lim P; Ratcliffe S; Silverman MM; Targum SD; Marder SR
    J Clin Psychiatry; 2017 Jun; 78(6):e638-e647. PubMed ID: 28682533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.